SCHEMBL1998504

SCHEMBL1998504

Oc1ccc(NNc2ccc(O)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.57
MAPT P10636 4/20 0.57
CA1 P00915 4/20 0.57
CA2 P00918 4/20 0.57
KDM4E B2RXH2 3/20 0.57
CYP3A4 P08684 3/20 0.57
KMT2A Q03164 3/20 0.57
CA12 O43570 3/20 0.57
ALOX15 P16050 3/20 0.57
MEN1 O00255 2/20 0.57
CA3 P07451 2/20 0.57
CA4 P22748 2/20 0.57
CA9 Q16790 2/20 0.57
CA14 Q9ULX7 2/20 0.57
HPGD P15428 2/20 0.57
RECQL P46063 2/20 0.57
HIF1A Q16665 2/20 0.57
HSD17B10 Q99714 2/20 0.57
LMNA P02545 2/20 0.57
NPC1 O15118 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28504196 0.88 ALDH1A1 (0.67) ALDH1A1MAPTCA1CA2KDM4E
SCHEMBL28622340 0.87 ALDH1A1 (0.50) ALDH1A1MAPTCA1CA2KDM4E
SCHEMBL22580334 0.86 ACHE (0.68) ALDH1A1MAPTCA1CA2KDM4E
SCHEMBL5580544 0.86 NQO2 (0.48) ALDH1A1MAPTCA1CA2KDM4E
SCHEMBL21337607 0.86 ALDH1A1 (0.68) ALDH1A1MAPTCA1CA2KDM4E
SCHEMBL18635011 0.84 CTSD (0.70) ALDH1A1MAPTCA1CA2KDM4E
SCHEMBL10495949 0.82 ALDH1A1 (0.50) ALDH1A1MAPTCA1CA2KDM4E
SCHEMBL14679832 0.80 ALDH1A1 (0.50) ALDH1A1MAPTCA1CA2KDM4E
SCHEMBL306231 0.79 ALDH1A1 (0.57) ALDH1A1MAPTCA1CA2KDM4E
SCHEMBL1921921 0.79 ALDH1A1 (0.57) ALDH1A1MAPTCA1CA2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119683814-A Simultaneous oxidation and coagulation water treatment process and equipment 安徽工业大学 2025-03-25 CN disclosed
US-20110230503-A1 6, 9-Disubstituted Purine Derivatives and Their Use as Cosmetics and Cosmetic Compositions SZUCOVA LUCIE 2011-09-22 US disclosed
US-7960397-B2 6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions INSTITUTE OF EXPERIMENTAL BOTANY, ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CZ) 2011-06-14 US disclosed
US-5245043-A Polyethers, polytriazoles THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) 1993-09-14 US disclosed
US-5245043-A Polyethers, polytriazoles THE UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR OF THE NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) 1993-09-14 US disclosed
US-5182356-A Reaction of di(hydroxyphenyl)-1,2,4-triazole monomers with activated aromatic dihalide or dinitro compounds THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) 1993-01-26 US disclosed
US-5182356-A Reaction of di(hydroxyphenyl)-1,2,4-triazole monomers with activated aromatic dihalide or dinitro compounds THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES NATIONAL AERONAUTICS AND SPACE ADMINISTRATION (US) 1993-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230503-A1 6, 9-Disubstituted Purine Derivatives and Their Use as Cosmetics and Cosmetic Compositions P2RY6, UMPS, PNP ALDH1A1 513/4885MAPT 2860/4885CA1 4839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.